The real-world evidence fusion study is now at full enrollment, allowing all eligible sites to recruit Motus patients, according to the release.
3Spine’s lumbar total joint replacement procedure and Motus device is a new technology, replacing the function of the disc and facet joints through a posterior approach. The technique reconstructs the functional spinal unit, like a hip or knee total joint replacement.
3Spine is still recruiting clinical trial patients for the study but is expecting U.S. approval of Motus by 2025.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
